Drug Profile
Research programme: anticancer therapies - Spirogen
Alternative Names: GWL-78; LAM156; LAM232; Project P014; Project P021; RMH-41; SG 2285; SG 2897; ZC 207; ZC 423Latest Information Update: 10 Aug 2021
Price :
$50
*
At a glance
- Originator Spirogen
- Class Benzodiazepines; Pyrroles
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Cancer
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 15 Oct 2013 Spirogen has been acquired by MedImmune
- 09 Feb 2011 Preclinical development is ongoing in United Kingdom